
Laboratory for Personalized Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia
Cancer, cancer stem cells, chronic inflammation, oxidative stress, cancer therapy, radiation therapy, cell death
Tanja Matijevic Glavan is a researcher at the Ruđer Bošković Institute in Zagreb, Croatia. Her work focuses on molecular biology and biomedical research, with particular interest in cancer biology and genomic analysis.

Cancer stem cells (CSCs) are a small subpopulation of cells within a tumor that have properties similar to normal stem cells. That means they are capable of self-renewal and can generate different types of cells found in a specific cancer. This makes them highly tumorigenic, meaning they are a key driver of tumor growth, and they are believed to be responsible for cancer initiation, recurrence, and metastasis. In this special issue we will present novel findings on cancer stem cells with special emphasis on innovative therapies, especially repurposing existing drugs and using phytonutrients for targeting cancer stem cells.